Table 5 Univariate analysis for risk factors associated with CAV-free survival 10 years after Htx

Recipient male

1.18

0.79–1.76

0.417

Recipient age

1.01

1.00–1.03

0.034

Recipient body mass index

1.03

0.99–1.08

0.137

Donor male

1.13

0.79–1.63

0.491

Donor age

1.04

1.03–1.06

<0.001

CAD

1.65

1.18–2.30

0.003

No CMV

-

-

Ref.

CMV disease

2.03

1.39–2.95

<0.001

Asymptomatic CMV infection

1.63

1.07–2.46

0.022

Donor-related CAD

1.49

0.86–2.59

0.153

Cold ischemic time

1.00

0.99–1.00

0.518

AMR at first year

1.18

0.71–1.96

0.531

TRS

1.51

0.84–2.72

0.165

TRS ≥ 2R

2.07

0.87–4.93

0.099

Hypertension

1.39

0.89–2.18

0.146

Diabetes mellitus

1.05

0.85–1.30

0.646

Ex-smoker

1.23

0.87–1.76

0.245

CMV serology

D−/R−

-

-

-

D−/R+

1.22

0.57–2.62

0.602

D+/R−

1.80

0.82–3.91

0.141

D+/R+

1.50

0.72–3.12

0.278